Evidence map›Paper›PMID 32281926›Full record

GuidelineBlood transfusion = Trasfusione del sangue2020

COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET).

Marco Marietta, Walter Ageno, Andrea Artoni, Erica De Candia, Paolo Gresele, Marina Marchetti, Rossella Marcucci, Armando Tripodi

2 registry-linked trialsAbstract readPractice Guideline
In one paragraph

Guideline in Blood transfusion = Trasfusione del sangue, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 190 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
190citing papers in PubMed, 12 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04408235 phase3unknown statusnot on this map

Randomised Controlled Trial Comparing High Versus Low LMWH Dosages in Hospitalized Patients With Severe COVID-19 Pneumonia and Coagulopathy Not Requiring Invasive Mechanical Ventilation

TypeinterventionalSponsorAzienda Ospedaliero-Universitaria di ModenaRan2020 to 2021Enrolled300ConditionsCOVID, Pneumonia, Viral, Coagulation DisorderArmsEnoxaparin
NCT04420312 completednot on this map

Incidence and Characteristics of Pulmonary Embolism in COVID-19 Patients Hospitalized for Acute Respiratory Syndrome

TypeobservationalSponsorFondation Hôpital Saint-JosephRan2020 to 2020Enrolled1,024ConditionsPulmonary Embolism, Covid-19
3 · Its place in the literature

Who cites it

190 citing papers in PubMed, 12 syntheses or guidelines pooled it.

  1. Prophylactic anticoagulants for non-hospitalised people with COVID-19.The Cochrane database of systematic reviews · 2023
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Epidemiology and Etiopathogeny of COVID-19.Advances in experimental medicine and biology · 2021
    Pooled it
  7. Antithrombotic Therapies in COVID-19 Disease: a Systematic Review.Journal of general internal medicine · 2020
    Pooled it
  8. Guideline
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. The Use of Therapeutic-Dose Anticoagulation and Its Effect on Mortality in Patients With COVID-19: A Systematic Review.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Pooled it
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. A systematic review on post-discharge venous thromboembolism prophylaxis in patients with COVID-19.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2023
    Review
  20. Review

130 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Marco MariettaDepartment of Oncology and Haematology, University Hospital, Modena, Italy.
Walter AgenoDepartment of Medicine and Surgery, "Insubria" University, Varese, Italy.
Andrea ArtoniIRCCS "Ca' Granda Maggiore" Hospital Foundation, "Angelo Bianchi Bonomi" Haemophilia and Thrombosis Center and "Fondazione Luigi Villa", Milan, Italy.
Erica De CandiaDepartment of Medicine and Translational Surgery, "Università Cattolica del Sacro Cuore", Faculty of Medicine and Surgery, Rome, Italy.
Paolo GreseleDepartment of Medicine, Section of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy.
Marina MarchettiImmunohematology and Transfusion Medicine Department, "ASST Papa Giovanni XXIII", Bergamo, Italy.
Rossella MarcucciDepartment of Experimental and Clinical Medicine, "Careggi" University Hospital, University of Florence, Italy.
Armando TripodiIRCCS "Ca' Granda Maggiore" Hospital Foundation, "Angelo Bianchi Bonomi" Haemophilia and Thrombosis Center and "Fondazione Luigi Villa", Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BetacoronavirusAcute Kidney InjuryBlood Coagulation DisordersComorbidityCoronavirus InfectionsCOVID-19Factor Xa InhibitorsFibrin Fibrinogen Degradation ProductsFibrinolytic AgentsHemostasisHeparinHumansItalyPandemicsPneumonia, ViralPulmonary EmbolismFactor Xa InhibitorsFibrin Fibrinogen Degradation Productsfibrin fragment DFibrinolytic AgentsHeparin

Identifiers

PMID32281926
PMCPMC7250682

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.